 |
Page History
...
| Data Element | Description | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCI _ID | Identifier assigned to this trial by the CTRP. | ||||||||||
| Lead_Org_ID | Identifier assigned to this trial by the lead organization. | ||||||||||
| Title | Official name of the protocol provided by the study principal investigator or sponsor. | ||||||||||
| ID | The
| ||||||||||
| Lead Org ID | The
| ||||||||||
| Title | The
| ||||||||||
| Lead Organization PO ID | The unique ID | Lead Org PO ID | Identifier assigned to the lead organization by the CTRP. For information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | ||||||||
| Lead _ Organization | The
| ||||||||||
| NCT ID | The
| ||||||||||
| CTEP ID | The
| Identifier assigned to this trial by the National Clinical Trial program (ClinicalTrials.gov). | CTEP_ID | Identifier assigned to this trial by the CTEP (Cancer Therapy Evaluation Program). For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | |||||||
| DCP ID | The
| ||||||||||
| Funding Mechanism | A
| ||||||||||
| NCI Division/Program | The NCI division or program identified in an IND, IDE, or grant record, as the
| ||||||||||
| Institution Code | The NIH institution associated with the trial, as identified in an IND, IDE, or grant record. For information, refer to NIH Institution Code Values, NIH Grant Institute Code Values, Abstracting INDs and IDEs, or Abstracting Funding. | Institution Code | | ||||||||
| IND/IDE Grantor | The
For information, refer to Abstracting INDs and IDEs. | ||||||||||
| IND/IDE Holder Type | The
For information, refer to Abstracting INDs and IDEs. | ||||||||||
| IND/IDE Number | The
| ||||||||||
| IND/IDE Types | A value indicating
| ||||||||||
| Section 801 Indicator | A value indicating
| Section_801_Indicator | Value indicating whether the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801. For more information, refer to Abstracting Regulatory Information. | ||||||||
| Principal _ InvestigatorPrincipal Investigator (PI) for the trial | The
| ||||||||||
| Sponsor _OrgOrg | The
information, refer to Abstracting Sponsors and Responsible Parties. | ||||||||||
| Responsible _Party | |||||||||||
| Summary_4_Funding_Sponsor | CTRP organizations listed as Data Table 4 Funding Sponsor for the trial. | ||||||||||
| Party | The
| ||||||||||
| Summary 4 Funding Sponsor | The
| ||||||||||
| Trial Status | Trial_Status | Current stage or state of a clinical trial or study relative to other stages and its ability to enroll participants/patients. For more information, refer to Abstracting Trial Statuses and The
| |||||||||
| Trial_Status_Date | Date on which the current trial status became effective. | ||||||||||
| Trial_Start_Date | |||||||||||
| Trial Status Date | The
| ||||||||||
| Trial Start Date | The
| ||||||||||
| Primary Completion Date | The
| Primary Completion Date | Date on which the final subject was examined or received an intervention, or the date on which that is expected to happen. For more information, refer to Abstracting Trial Statuses. | ||||||||
| Primary Completion Date Type | A
| ||||||||||
| Submitting _ Org _ Name | The name of the organization that submitted the trial. | ||||||||||
| Current Processing Status | The
| Current Processing Status | Value indicating the current processing status of the trial. For more information, refer to . | ||||||||
| Study _ Category | The | ||||||||||
| Submission Number | |||||||||||
| |||||||||||
| Submission Number | A
| ||||||||||
| Trial Submission Type | A value indicating
| Trial Submission Type | | ||||||||
| Trial Summary Report Sent Date |
...
| hidden | true |
|---|
...
| The date on which the system sent the Trial Summary Report (TSR) to the principal investigator or trial submitter. For information, refer to Processing Trial Milestones. |
